• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

9.790 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
7 A-Rated Healthcare Stocks to Buy for the Long Haul ↗
November 01, 2021
It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future. 
Via InvestorPlace
News headline image
Expert Ratings For Prothena Corp ↗
September 30, 2021
Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA 
Via Benzinga
News headline image
Expert Ratings For Prothena Corp ↗
September 27, 2021
Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA 
Via Benzinga
News headline image
What 8 Analyst Ratings Have To Say About Prothena Corp ↗
September 20, 2021
Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA 
Via Benzinga
News headline image
With Prothena Up Over 500% This Year, Is It Too Late to Get in? ↗
September 18, 2021
Promising drug candidates could lead to a best-in-class Alzheimer's treatment. 
Via The Motley Fool
News headline image
Expert Ratings For Prothena Corp ↗
September 17, 2021
Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA 
Via Benzinga
News headline image
Expert Ratings For Prothena Corp ↗
September 14, 2021
Within the last quarter, Prothena Corp (NASDAQ:PRTA) has observed the foll... 
Via Benzinga
What 9 Analyst Ratings Have To Say About Prothena Corp ↗
August 09, 2021
Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA 
Via Benzinga
Where Prothena Corp Stands With Analysts ↗
July 19, 2021
Within the last quarter, Prothena Corp (NASDAQ:PRTA) has ... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
News headline image
Return on Capital Employed Insights for Prothena Corp ↗
September 02, 2021
According to Benzinga Pro, during Q2, Prothena Corp (NASDAQ:PRTA) earned $27.95 million, a 187.04% increase from the preceding quarter. Prothena Corp also posted a total of $60.07... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
August 09, 2021
Jefferies raised the price target on Tesla, Inc. (NASDAQ: 
Via Benzinga
Where Prothena Corp Stands With Analysts ↗
July 13, 2021
Prothena Corp (NASDAQ:PRTA) has observed the following an... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗
September 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
News headline image
Recap: Prothena Corp Q2 Earnings ↗
August 05, 2021
Shares of Prothena Corp (NASDAQ:PRTA) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 187.88% year over year to $0... 
Via Benzinga
News headline image
Why Is Novo Nordisk Buying a Rare-Disease Candidate? ↗
July 24, 2021
The company is mainly known for its diabetes drugs but has some background in rare-disease drugs. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
July 13, 2021
Wells Fargo lowered C.H. Robinson Worldwide, Inc. (NASDAQ: 
Via Benzinga
News headline image
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Topics Intellectual Property
News headline image
Mid-Afternoon Market Update: Dow Surges Over 100 Points; State Auto Financial Shares Jump ↗
July 12, 2021
Toward the end of trading Monday, the Dow traded up 0.34% to 34,987.02 while the NASDAQ rose 0.08% to 14,713.30. The S&P also rose, gaining 0.26% to 4,380.72. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Mid-Day Market Update: Crude Oil Down 1%; Celldex Therapeutics Shares Spike Higher ↗
July 12, 2021
Midway through trading Monday, the Dow traded up 0.28% to 34,967.12 while the NASDAQ rose 0.08% to 14,714.09. The S&P also rose, gaining 0.23% to 4,379.69. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Mid-Morning Market Update: Markets Mostly Higher; Novo Nordisk To Acquire Prothena's ATTR Amyloidosis Program ↗
July 12, 2021
Following the market opening Monday, the Dow traded up 0.32% to 34,981.25 while the NASDAQ fell 0.07% to 14,691.53. The S&P also rose, gaining 0.15% to 4,376.17. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Novo Nordisk To Buy Prothena's ATTR Amyloidosis Program For Up To $1.2B ↗
July 12, 2021
Novo Nordisk A/S (NYSE: NVO) will acquire Prothena Corporation plc's (NASDAQ: PRTA) and clinical stage antibody PRX004 and broader ATTR amyloidosis... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
July 09, 2021
Gainers Galectin Therapeutics (NASDAQ:GALT) shares moved upwards by 35.0% to $3.73 during Friday's regular session. As of 12:30 EST, Galectin Therapeutics's stock... 
Via Benzinga
News headline image
64 Biggest Movers From Friday ↗
July 12, 2021
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share. SGOCO Group, Ltd. (NASDAQ: SGOC)... 
Via Benzinga
Topics Initial Public Offering
News headline image
40 Stocks Moving In Friday's Mid-Day Session ↗
July 09, 2021
Gainers Stamps.com Inc. (NASDAQ: STMP) jumped 63.7% to $323.63. Software investment firm Thoma Bravo inked an agreement to acquire e-commerce shipping solutions provider Stamps.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 18, 2021 ↗
June 18, 2021
Upgrades According to JP Morgan, the prior rating for Orion Engineered Carbons SA (NYSE: 
Via Benzinga
News headline image
Return On Capital Employed Overview: Prothena Corp ↗
June 18, 2021
In Q1, Prothena Corp (NASDAQ:PRTA) posted sales of $160.00 thousand. Earnings were up 5.94%, but Prothena Corp still reported an overall loss of $32.11 million. Prothena Corp... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
June 17, 2021
Gainers Midatech Pharma (NASDAQ:MTP) stock rose 36.76% to $2.79 during Thursday's regular session. Midatech Pharma's stock is trading at a volume of 69.8 million... 
Via Benzinga
News headline image
50 Biggest Movers From Yesterday ↗
June 18, 2021
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ... 
Via Benzinga
Topics Initial Public Offering
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap